Risk of Adverse Neurocognitive Outcomes With PCSK-9 Inhibitors.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.03.583
Abstract: The paper by Robinson et al. [(1)][1] suggested that low-density lipoprotein cholesterol (LDL-C) values read more here.
Keywords: cardiology; risk adverse; adverse neurocognitive; pcsk inhibitors ... See more keywords